Applying Metaverse Technologies to Human-Computer Interaction for Healthcare

The concept of the metaverse signifies the forthcoming stage of development of the Internet, wherein it will facilitate the creation of virtual worlds that are enduring, decentralized, and capable of providing immersive experiences in real time. The metaverse has vast potential for utilization in the domains of life sciences and healthcare, hence motivating investigations in contemporary trends, early adoption use cases, and the forthcoming opportunities it presents. The metaverse also possesses the capacity to fundamentally transform decentralized clinical trials through the elimination of physical and geographical constraints. This change in thinking entails the relocation of clinical trials from conventional settings to the comfort and convenience of patients’ residences, resulting in improvements in health behavior, medication adherence, remote monitoring, and other associated factors.

Applying Metaverse Technologies to Human-Computer Interaction for Healthcare focuses on the current developments in the metaverse, investigates its applications in the life sciences and healthcare industry based on metaverse powered human−computer interactions (HCI), analyzes early adoption use cases that provide measurable commercial benefits, and anticipates prospects in this rapidly evolving domain.

The book examines the treatment, management, and prevention of illnesses with the use of immersive therapeutics that use augmented reality (AR), virtual reality (VR), and mixed reality (MR). It examines applications in cognitive therapy, support groups, psychiatric examinations, rehabilitation, and even physical therapy The book covers how healthcare practitioners have the capability to provide such services as diagnosis, treatment, monitoring, and care in remote settings, through the utilization of AR headsets and wearable devices. It concludes by discussing the continuous development of technology to facilitate the growth and maturation of the metaverse, hence enabling substantial business benefits for the life sciences and healthcare industries.